n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Chronic Disease in 2 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Souza, FC | 1 |
| Gobbato, NB | 1 |
| Maciel, RG | 1 |
| Prado, CM | 1 |
| Martins, MA | 1 |
| Leick, EA | 1 |
| Tibério, IF | 1 |
| Zhang, P | 1 |
| Xu, X | 1 |
| Hu, X | 1 |
| van Deel, ED | 1 |
| Zhu, G | 1 |
| Chen, Y | 1 |
2 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Chronic Disease
| Article | Year |
|---|---|
Effects of corticosteroid, montelukast and iNOS inhibition on distal lung with chronic inflammation.
Topics: Acetates; Amidines; Animals; Anti-Inflammatory Agents; Benzylamines; Chronic Disease; Cyclopropanes; | 2013 |
Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure.
Topics: Amidines; Animals; Aortic Diseases; Atrial Natriuretic Factor; Benzylamines; Cardiomegaly; Chronic D | 2007 |